0001209191-20-052459.txt : 20200930 0001209191-20-052459.hdr.sgml : 20200930 20200930163704 ACCESSION NUMBER: 0001209191-20-052459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200928 FILED AS OF DATE: 20200930 DATE AS OF CHANGE: 20200930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manning Paul B CENTRAL INDEX KEY: 0001494695 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39536 FILM NUMBER: 201212646 MAIL ADDRESS: STREET 1: 200 GARRETT STREET SUITE S CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: 212.551.8702 MAIL ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-28 0 0001806310 Taysha Gene Therapies, Inc. TSHA 0001494695 Manning Paul B C/O TAYSHA GENE THERAPIES, INC. 2280 INWOOD ROAD DALLAS TX 75235 1 0 1 0 Common Stock 2020-09-28 4 C 0 3275205 A 3275205 I See Footnote Common Stock 2020-09-28 4 C 0 2008158 A 2008158 I See Footnote Common Stock 2020-09-28 4 C 0 11944 A 2020102 I See Footnote Series A Preferred Stock 2020-09-28 4 C 0 3006155 0.00 D Common Stock 3275205 0 I See Footnote Series A Preferred Stock 2020-09-28 4 C 0 1843193 0.00 D Common Stock 2008158 0 I See Footnote Series B Preferred Stock 2020-09-28 4 C 0 10963 0.00 D Common Stock 11944 0 I See Footnote Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one for-1.0895 basis, and had no expiration date. The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. /s/ Kamran Alam, Attorney-in-Fact 2020-09-30